Emily Holbrook MRCVS, Garth Tozer MRCVS, Dr Richard Dixon and Ken Davison MRCVS have all won a Best Practice Employer Award from Novartis Animal Health after glowing nominations from the staff at their practices.
In addition, Katherine Corbett VN from Nine Lives Veterinary Centre won a special new award, worth £500, for the veterinary nurse that in the judges' opinion had best used the opportunities given to her by her boss, Emily Holbrook.
Katherine's first question when told of her win really demonstrates the commitment that veterinary nurses will give a good boss: "Can I spend it on buying one of Kruuse's Buster ICU cages for the practice? Emily has given me so much; I'd love to give something back."
Rachel Smithson, Marketing Manager at Novartis said: "All of our winners were asked what steps they take to ensure a happy team. Their answers were almost unanimous. Empower your staff. Give them responsibility, and if that means accepting the occasional mistake, then do so. Praise them for a job well done. Thank them regularly. Not only will it make your practice a better working environment, but as Katherine demonstrates, your staff will probably go to extraordinary lengths to support you. That translates into a more profitable practice, and higher standards of veterinary care."
The story is covered in full in the August and September editions of Veterinary Practice magazine, downloadable from www.vetsurgeon.org
Sarah Palmer (left) of Novartis Animal Health makes the presentation to head nurse Katherine Corbett and veterinary surgeon Emily Holbrook of Nine Lives Veterinary Practice; behind them are Anne Corbett (receptionist), Lindsay Harrison (nursing assistant), and Laura Steele (veterinary surgeon).
Kenneth Agnew from Novartis Animal Health prepares to present Kenneth Davison with his Best Practice Employer Award, whilst the team toast their boss.
Veterinary Nursing Assistant Abby Brown (left) and Abby Roberts from Novartis Animal Health toast Garth Tozer, Novartis Best Practice Employer Award winner.
Donna Lewis (BVNA), and Novartis Animal Health CEO George Gunn present Dr Richard Dixon with his award.
The Kennel Club has announced it will be launching the Veterinary Practice Guide to Dog Health, a new guide to dog health for veterinary surgeons at the BVA Congress 2010 (Sept 23rd - 25th).
According to the organisation, The Veterinary Practice Guide to Dog Health has been specially developed to provide veterinary surgeons and other practice staff with a handy, updatable resource which covers a range of topics including breed specific information for all 210 recognised pedigree breeds and the range of health testing available to breeders and owners.
The guide contains information on the Kennel Club's Accredited Breeder Scheme, which currently has around 5,300 members who commit to good breeding practice, and the Fit For Function: Fit For Life campaign which aims to ensure that all dogs are able to lead their lives to the full by ensuring that they are fit enough to fulfil the function for which they were originally developed.
The guide provides details about the reporting of operations which alter the natural conformation of a dog, and a sample form which veterinary surgeons can copy and then use to report such operations to the Kennel Club. It also contains a full set of Kennel Club information guides covering a wide range of topics and examples of Kennel Club registration certificates for dogs from both standard registrations and Kennel Club Accredited Breeders to help advise puppy owners what to expect when buying a Kennel Club-registered dog.
Other topics included in the manual are a range of Kennel Club initiatives which veterinary surgeons may find useful to pass on to their clients, such as information on the Good Citizen Dog Training Scheme, the UK's largest dog training programme, and Petlog, the UK's largest microchipping and pet reunification database.
The Kennel Club's Veterinary Advisor, Nick Blayney said: "The Kennel Club Veterinary Practice Guide to Dog Health is intended to assist veterinary surgeons and all practice staff gain information about the two hundred or more breeds of dog recognised by the Kennel Club and any related health issues.
"The Kennel Club is very aware that veterinary surgeons are keen to promote the breeding of healthy puppies, but would find it useful to obtain information about the many health tests and screening schemes available and recommended for each breed. This manual is intended to provide detailed advice on these tests and schemes on a breed by breed basis to assist vets in helping clients to understand the different conditions which may affect individual breeds."
The guide will be made available as an A4 ring binder, with the first fifty available at the BVA Congress. Recipients will be asked to agree to a follow-up visit from one of the Kennel Club's Accredited Breeder Advisors, whose role involves inspecting the breeding premises of the scheme's members to ensure that the standards required by the scheme are kept, and also establishing relationships with veterinary surgeons around the country. There are currently 14 Kennel Club Accredited Breeder Advisors across the UK and they will also be responsible for distributing the remaining copies to veterinary surgeries in the future.
Alongside the launch of the guide, a new dedicated area for veterinary surgeons has been added to the Kennel Club website at www.thekennelclub.org.uk/vets. This will include links to many of the subjects contained in the manual, and will initially feature the top 20 breeds registered in the UK. Future updated content will be added to the website as it becomes available, and the manual will subsequently be produced as a computer disk for wider distribution and convenience.
Veterinary surgeons who are not attending this year's BVA Congress, but wish to obtain a copy of the Veterinary Practice Guide to Dog Health, should visit the new section of the website and complete the request form. A representative of the Kennel Club's Health and Breeder Services team will then make contact to establish a suitable date and time for an Accredited Breeder Advisor to visit.
From the beginning of October this year, the electronic recording of pig movements will be written into legislation.
Following a recent consultation, Defra intends to amend the existing Pigs, Records, Identification and Movements Order (PRIMO) 2007 to reflect the requirement of pre-notification of movements.
Dorothea Schiemann of BPEX said: "There will be a transitional period of six months for the phasing out of the paper-based AML2 forms, planned to start from 1 October 2011. This will give producers and businesses the opportunity to adjust to the change in process.
"From April 2012 the AML2 paper forms will cease to be a valid method of reporting movements. Pig movements will either have to be reported using the free eAML2 online service or the free eAML2 bureau service and there will also be third party agents such as marketing groups or the British Pig Association."
Following extensive trialling, the eAML2 system for farm to slaughter movements was launched in April 2011 across England and Wales. The functions for movements from farm to farm, market, collection centre and show, and for import and export, will be introduced in due course.
Benefits include the fact that the industry will have a realistic herd register providing accurate and timely information. This will enable better communication and control in the event of disease outbreak. There will be no need to fill in the same information again and again as the eAML2 service will pre-populate the basic information automatically. Also, when pigs are sent to slaughter, the system combines the movement licence and Food Chain Information (FCI) form in one, which will save producers time.
For more information and to register to use the system go to: http://www.eaml2.org.uk/
Novartis Animal Health has announced the results of a survey of dairy and beef farmers which found that 39% of those who found Bovine Viral Diarrhoea (BVD) present in their herd did not then go on to test for persistently infected (PI) animals.
Any calf born from a BVD persistently-infected cow will be born Persistently Infected with the virus and cannot be cured. As a result, future vaccination of this animal against the virus is rendered ineffective and the affected animal will be a source of the virus, spreading infection within the herd.
With young cattle being the source of PI's and reservoirs of infection within a herd, failure to test, identify and then deal with PI livestock represents the most significant problem facing the industry when trying to eradicate BVD.
Professor Joe Brownlie from the Royal Veterinary College and current chairman of the BVD Scientific and Technical Working Group, said: "Of the 61% of farmers that did do follow up tests for PI's once BVD had been detected in their herd, one third found one or more PI's within the stock holding.
"However, one third of farmers who identified having active BVD infection in their herd then failed to go on and carry out individual animal testing; of those that did, nearly half discovered one or more individual PI's within their herd".
"It just shows that the disease can be hidden, and farmers could be in the dangerous position of potentially missing PI animals that are in their herd; PI's that can continue to spread the BVD virus amongst other cattle and pass on their PI status to any calves they produce. It is hugely important to be thorough and consistent in your testing as part of an agreed herd health plan"
The survey also indicated that action needs to be taken to educate farmers about what to do once BVD and, most significantly, PI's are discovered amongst a herd.
Professor Brownlie said: "There is much evidence from this survey to encourage the industry in how it is tackling this disease, however there is still a great need for clear direction. The survey indicated that 20% of farmers wrongly believe that PI animal's will eventually become non-infective and that 25 % believe that calves born of PI cows will not always have PI calves themselves.
"All of these perceptions are incorrect and can lead to reservoirs of the disease being allowed to remain not only within individual herds, but geographical regions as well; seriously hindering the eradication of the virus in England and Wales".
With nearly half of farmers saying that they talked to vets - their main source of information about BVD - only once or less a year, Professor Brownlie said it is unsurprising that many farmers did not show a greater understanding of BVD beyond biological side effects present in the infected cattle: "About 50% of farmers surveyed were unsure as to what types of tests need to be carried out to detect the infection in their livestock and 32% of respondents were unaware that correct vaccination of livestock against BVD can protect both the cow and unborn calf".
Novartis says that while BVD is still regarded by farmers as one of the top bovine diseases, other health issues such as mastitis and tuberculosis are given much greater attention. This lack of focus on BVD is exacerbated by the lack of sound information of the financial implications of the infection on their herd.
Professor Brownlie said: "The side effects of BVD appear to be overlooked in financial terms, but the infection can severely hinder a herd's financial productivity due to poor health, reduced milk yield and loss of reproductive efficiency.
Caroline Dawson from Novartis Animal Health said:"Perhaps by aiding understanding of the financial cost of the virus, we can encourage farmers to take more proactive steps to combat BVD. As such, I am pleased to announce that that the FAB panel has initiated a follow on project to carry out detailed research with regards to the financial impact of BVD on farms and is due to report findings in the new year".
(Photograph shows, left to right, James Russell MRCVS (McMurtry & Harding), Caroline Dawson (Novartis Animal Health), Tony Brooks (Brighthams Farm), Professor Joe Brownlie(RCVS)
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
The survey, which takes about three minutes, will assess horse owners’ experiences of strangles and includes questions on the disease including preventative measures and vaccination.
There will be a prize draw from completed entries and the winner will get two VIP tickets to Your Horse Live 2025.
Rachel Harrison-Osborne MRCVS, equine field manager at Dechra said: “The strangles survey will provide us with a valuable insight into horse owners’ experiences of the disease and will enable us to identify any trends that may exist to help us support owners who wish to put in place preventative measures to help prevent strangles.”
https://forms.office.com/e/85gzEd7J7A
Photo: Redwings Horse Sanctuary
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
Virbac has announced that it will repeat its EasOtic promotion through which practitioners that make multiple purchases of the award-winning otitis treatment can claim an ear model and specialist ear instrument kit.
The models, which show the anatomy of a healthy canal on one side and the changes associated with chronic damage on the other, are approximately 15cm high and can be used as a visual aid to show clients the consequences of untreated chronic ear disease.
The specialist ear instrument kits, worth £100, have been designed in consultation with veterinary dermatologists. They consist of a haemostat, ear forceps, three various cerumen scoops and a Spreulls ear-flushing needle.
Product Manager Chris Geddes MRCVS said: "Basically it's the best ear equipment for daily use by practitioners. Last year we were overwhelmed by the demand of both promotions, so we've decided to repeat the offer again this year."
The models and kits are available with multiple purchases of EasOtic and the neutral pH glycotechnology ear cleaner Epi-Otic.
For details of how you can obtain a model and/or kit for your practice contact your local Virbac territory manager or call Virbac on 01359 243243.
According to the calculator, the most expensive animal is - by virtue of its longevity - the tortoise (£27,787 over 75 years), followed by a small dog (£19,224 over 15 years), a large dog (£17,234 over 11.5 years) and a medium-sized dog (£16,828 over 11.5 years). A cat comes in at £12,322 over 16 years. A chicken will set you back £4,701 (it's not clear whether they've offset the money you'll save in eggs). The cheapest is a fish, at £914.
Common ‘Pet Dangers’ include:
The poster also reinforces the importance of S.P.E.E.D when dealing with poisoned pets:
To get your free poster, visit https://www.tvm-uk.com/pet-dangers-order-free-display-materials-for-your-practice/ or email help@tvm-uk.com.
Rig Vet Recruitment has added a new title to its range of personnel recruitment guides with the introduction of “Rig’s Practice VN Guide”.
The guide covers all the issues you might face when employing a locum nurse, and gives a handy checklist of things to cover with your temporary employee to help make sure that he or she gets up to speed as fast as possible.
“We were so pleased with the positive responses we received when we launched the locum vet guides last year that locum vet nurses’ versions were an obvious next step,” said Justin Carpenter, Rig Vet Recruitment Managing Director.
He added: “At the end of last year, we conducted a survey among some vet nurses and frankly were surprised at how little information on practice admin and procedures some VNs were given on their first day,” Justin continued. “For example, 88 per cent were not given a formal induction, 78 per cent were not advised on fire and health & safety regulations, and when expected to undertake reception work, 97 percent were not informed on phone protocols or appointment systems.
The guide is available free of charge from Rig Veterinary Recruitment: enquiries@rigvets.co.uk
Rig Vet Recruitment are on stand number 719 at BSAVA Congress 2008.
Sarah Fitzpatrick, Head of Partnerships and Events at BSAVA said: “We’re absolutely delighted to be working in partnership with CVS to support the small animal veterinary profession, through the development and upskilling of veterinary professionals.
"The BSAVA manuals are a go-to vet resource, and by providing this access to CVS they become even more valuable to the community through their use in practice and in consults.”
Joseph Williams, Veterinary Director for the CVS Small Animal Division said: “At CVS we are passionate about giving the best possible care to animals. We take our responsibility seriously to help colleagues to do that, investing in training and through the support given via our Hub Clinical Leadership team.
"BSAVA manuals have long been a trusted reference point for clinical information in our industry. We’re excited to partner with the BSAVA and now, with access to this great resource, every CVS clinician, whether in the consult room, prep room or on a visit, is now just a couple of clicks away from 46 manuals with over 1400 chapters covering all disciplines from anaesthesia to wildlife casualties.’’
Millpledge has launched Promodulate Probiotic Powder, which, according to the company, combines beneficial bacteria with a pre-biotic, vitamins and electrolytes to rebalance gut flora, fluid and electrolyte balance in cats and dogs.
The powder is presented in a 5 day course of sachets for ease of dispensing, or in a 50g tub for longer term use.
Millpledge says micro-encapsulated Entrococcus Faecium SF68 NCIMB 10415 - 667 x 106 CFU/g helps to recolonise the gut and maintain competitive exclusion of harmful bacteria whilst the preferred prebiotic Fructooligosaccharide (FOS) provides a targeted source of sugars to fuel the Entrococcus Faecium. Electrolytes are included to help maintain the isotonic fluid balance in the patient, and vitamins to maintain the normal feed conversion ability of the gut to absorb and bind nutrients present in the diet.
Millpledge suggests that Promodulate is beneficial alongside antibiotic therapy and can be used as an aid to maintaining the immune response in newborns as well as animals in the later stages of life. Promodulate is also recommended as an aid to restoring normal digestive function and to help maintain normal cholesterol levels and electrolyte and fluid balance.
For more information, please click here.
WebLeC has launched a monthly online equine CPD service.
One hour live interactive sessions will take place every third Thursday at 7:30 pm. A single meeting costs £30 plus VAT, or savings can be made by taking out a flexible subscription that allows the user to choose any 12 meetings for the cost of 10 over a period of up to 24 months.
The next meeting is on 22nd September and is entitled: Colic Decision making: When to wake up the surgeon and what pain control to use. The presenter is Debra Archer form the University of Liverpool. Further details and registration links can be found at: http://www.ledstonequine.co.uk/weblec_lectures/colic.html
In addition, a recording of WebLeC's 6th meeting, which was held in partnership with BEVA and the VDS and dealt with the new guidelines and forms for pre-purchase examinations of horses, is now available to view free online at: www.bitly.com/weblecbevaPPE. Use the password: b3va to get access, and you will receive a CPD certificate if you fill in the registration form.
WebLeC has also been asked to host BEVA's online CPD and will be announcing further details of their meetings soon.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
BCF Technology has launched a competition to win a top of the range digital radiography system from its Cuattro range for 6 months.
To enter the competition, you need to record a short video (up to 2 minutes) explaining how the DR system would transform your imaging function. BCF is asking entrants to be as creative as possible as the voting will be open to the public. The company will pick a shortlist of finalists and then invite the public to vote for a winner on its Facebook page and website.
The competition is open to both small animal and equine vets, for the following systems:
Sarah O'Grady from BCF said: "Having a Cuattro DR system could make a huge difference to either a small animal or an equine practice. For a small animal vet practice that doesn't currently have a DR system, they will love the difference it makes to X-ray studies. Diagnostic images are produced in seconds and re-takes are almost non-existent. A Wireless Slate 3+ can greatly improve the ease of in-stable operations and procedures. With the removal of wires, these procedures run much smoother. You will also be surprised by the improvement in image quality."
The closing date for the competition is 30th November 2013.
To enter your video:
The winner will be required to arrange insurance for the system during the time they have the system. Full terms and conditions can be found on the BCF website.
To find out more visit the BCF website or Facebook page or call +44 (0)1506 460 023.
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
Intervet / Schering-Plough has announced that its leptospirosis vaccine, Nobivac Lepto 2, is now back in stock at all wholesalers and that the production delay affecting supply has been fully resolved.
David Hallas, general manager, Intervet / Schering-Plough Animal Health, said: "We foresee no further supply difficulties on Nobivac Lepto 2. I very much regret the inconvenience experienced over this difficult period and I would like to express my sincere gratitude to all of our customers for their patience, understanding and support.
"A combination of advancing production and a very timely batch release process has enabled us to re-introduce Nobivac Lepto 2 ahead of the previously-indicated timing of early May, and we are pleased that we have been able to deliver on the assurances that we made back in January."
The company says that current stock levels and planned deliveries are all in place.
Ken Elliott, Marketing Manager for Intervet/Schering-Plough Animal Health's Companion Animal Business, said: "Orders should be placed with wholesalers in the usual way but we advise practices that have outstanding orders, or think they may have outstanding orders, to check the status with their wholesaler."
Mars Veterinary is launching the Wisdom Panel Insights mixed breed dog DNA test at the Kennel Club's Discover Dogs event this weekend.
According to the company, more than 2 million dogs in the UK are mixed breed, and it is likely that many owners are unsure of their pet's parentage.
Now, with the swipe of a cheek swab, Wisdom Panel Insights can determine the ancestry of a mixed breed dog by testing for more than 185 breeds, which Mars Veterinary says is the largest database of any canine DNA test on the market. Within three weeks, dog owners are emailed an official Ancestry Report that reveals the dog's genetic background. This, it is claimed, will help owners provide better training, nutrition and exercise for their pet, and will also alert them to any disease predisposition their dog may have.
The test will be on sale for the first time at Discover Dogs at Earl's Court, and from the website: www.wisdompanel.co.uk. It costs £59.99 inc. vat, discounted for Kennel Club registered dogs.
Caroline Kisko, Secretary of the Kennel Club, said: "A dog's ancestry can influence him in surprising ways. Obvious and not-so-obvious physical traits plus behaviours like digging, herding and barking all come from the various breeds in a dog's family tree. Once an owner understands a dog's natural tendencies, it makes it possible to create a tailored training, exercise and nutrition program to fit his one-of-a-kind needs. This is one of many innovative products that dog owners and lovers will find at Discover Dogs this weekend."
The Animal Health Trust has presented the results of a study which has identified a significant link between hind limb lameness and saddle slip, showing consistent saddle slip in some horses with hind limb lameness, even when the lameness is fairly subtle and difficult to detect.
According to the AHT, saddle slip in sports horses is a well-recognised problem that can occur for a variety of reasons, including asymmetry in the shape of the horse's back, riders sitting crookedly and ill-fitting saddles. Sue Dyson, Head of Clinical Orthopaedics at the Centre for Equine Studies at the Animal Health Trust, had also observed that saddle slip may occur because of hind limb lameness. The intention of the study, therefore, was to find out more about the interrelationships between the horse, saddle and rider and to document the frequency of occurrence of saddle slip in horses with hind limb lameness compared with other horses.
The research was undertaken by Sue Dyson and Intern Line Greve and was presented at the British Equine Veterinary Association (BEVA) Congress last month. It is thought to be the first study of its kind, and was supported by the Saddle Research Trust (SRT). The SRT is a charitable organisation, aiming to facilitate research and provide support as well as advice on the influence of the saddle on the welfare and performance of horses and riders.
The study assessed 128 horses of varying size, age and type. The degree of lameness of each horse was graded; back shape and symmetry were measured and saddles assessed for symmetry and fit. Each horse was ridden by at least two riders and rider straightness plus weight were recorded. The grade of saddle slip, whether it occurred with more than one rider, and whether saddle slip was influenced by the direction of movement or the diagonal on which the rider was sitting were also noted.
The saddle consistently slipped to one side in 54% of horses with hind limb lameness, compared with 4% of horses with fore limb lameness, 0% with back pain and/or sacroiliac joint region pain and 0% of non-lame horses. Diagnostic analgesia was subsequently used to abolish the hind limb lameness and this eliminated the saddle slip in 97% of cases.
Sue said: "Our findings emphasise the need to educate owners, veterinarians, physiotherapists, trainers, riders and saddle fitters that saddle slip is frequently an indicator of lameness, not necessarily a manifestation of an ill-fitting saddle or asymmetric shape of the horse's back. Detection of saddle slip provides an opportunity for the owner, riders and trainers to detect low-grade and subclinical lameness, with important welfare consequences."
Further scientific studies are planned, with the support of the Saddle Research Trust, in order to build on these findings. To this end the SRT is currently seeking an honorary fundraiser to help secure ongoing financial support. For further information contact Anne Bondi on 07775 912202 or email annebondi@me.com.
1An investigation of the relationship between hindlimb lameness and saddle slip, L. Greve and S.J. Dyson, Centre for Equine Studies, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk, CB8 7UU, UK.
Royal Canin has announced that it has established a team of three specialist advisors to work directly with veterinary practices to help develop and improve their weight management clinics, client retention and product sales.
The Pet Weight Care Team will also provide practical training to all practice staff on how to recognise weight problems, communicate sensitively with pet owners and treat the problem effectively.
The first advisor to join the team is Shelley Holden VN (pictured right), who has 10 years' experience as the nurse for the Royal Canin Weight Management Referral Clinic at The University of Liverpool. Shelley has spent time running successful nursing clinics in general practice and lecturing internationally on the topic of obesity. She said: "I have spent many years dedicating my time caring for overweight pets, and the number of cases we see is continuing to rise. It's really important that as obesity specialists we can offer hands-on support to practices to assist them with helping to decrease the number of overweight pets they see.
"Our aim will be to offer specialist training through a number of sessions to practices who wish to improve their weight management clinics. We'll spend time with all members of staff helping them to feel more confident when dealing with owners who have overweight pets. The training will include all aspects of weight management including how to approach owners, Body Condition Scoring and the 30 minute consult. Staff will also be trained on how to support owners throughout the weight loss program and during the maintenance phase."
Royal Canin says the training will also cover the prevention of obesity in pets, how to advise owners on the appropriate diets post neutering and how to manage the animal's weight and calorie intake throughout their lives. The Pet Weight Care Team will be encouraging practices to carry out weight management assessments alongside medical examinations to ensure that potential weight problems are dealt with quickly.
The company says that practices that receive training will be followed up with on a regular basis to provide further support and training as needed.
For more information, contact your Royal Canin Veterinary Business Manager.
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.